Our Unique Consortium

Sydney Catalyst is a multi-disciplinary, multi-institutional endeavour established with core funding from the Cancer Institute NSW and based at the University of Sydney.

Read more

Event
Body Composition Analysis by Computed Tomography Education Workshop 2018

Workshops and Masterclasses

Body Composition Analysis by Computed Tomography Education Workshop 2018

Chris O'Brien Lifehouse

In partnership with the University of Alberta, Edmonton, Canada Wednesday 27th - Friday 29th June 2018 Workshop participants will have the opportunity to complete certification requiremen...

Read more
Event
Postgraduate and Early Career Symposium 2018

Symposia

Postgraduate and Early Career Symposium 2018

  Registration       Programme          Virtual Symposium       Faculty Speakers   The 7th annual Sydney Cat...

Read more
News
Pilot & Seed Funding Applications now open

News Articles

Pilot & Seed Funding Applications now open

An essential component of the Sydney Catalyst program is funding to support the development of new concepts and projects. This includes projects identified and developed under the direction and l...

Read more
News
Sydney Catalyst February 2018 Newsletter

Newsletters

Sydney Catalyst February 2018 Newsletter

2018 is upon us and we would like to take this opportunity to wish all our valued members a very happy New Year. We hope you enjoyed some much needed time out with loved ones over the Christma...

Read more
News
A message on behalf of the Sydney Catalyst Governing Council

News Articles

A message on behalf of the Sydney Catalyst Governing Council

As Sydney Catalyst broaches it 7th year of working in collaboration with our members to improve outcomes for people affected by cancer, we wanted to take the opportunity to highlight some of o...

Read more
News
Key Support for Garvan's Cancer Research in 2018 and Beyond

News Articles

Key Support for Garvan's Cancer Research in 2018 and Beyond

Garvan researchers are thrilled to be among the recipients of grants in recently announced funding schemes from the National Breast Cancer Foundation and Cancer Australia. The funding will pro...

Read more
Research
Helen McGuire: Development of a novel test to predict clinical response to checkpoint therapy in lung cancer and mesothelioma

T1 | Flagship 2 Pilot and Seed

Helen McGuire: Development of a novel test to predict clinical response to checkpoint therapy in lung cancer and mesothelioma

Immune checkpoint inhibitor therapy has provided new hope to cancer patients whose tumours have resisted conventional therapy. One of the most recent success stories has been effective treatmen...

Read more
ImmunotherapyNew therapies and diagnosticsLung cancerMesothelioma
Research
David Thomas & Team: Molecular Screening and Therapeutics Program (MOST)

T1,T2 | Sydney Catalyst Supported

David Thomas & Team: Molecular Screening and Therapeutics Program (MOST)

The rapid advance in genomic technologies presents the unprecedented opportunity to molecularly phenotype cancers and link genetic information to therapeutic opportunities for individual patie...

Read more
Genetics/genomicsPersonalised medicineNew therapies and diagnostics
Research
Sydney Catalyst: Embedding Research in Cancer Healthcare (EnRICH)

T1,T2,T3 | Flagship 1 EnRICH

Sydney Catalyst: Embedding Research in Cancer Healthcare (EnRICH)

The program will develop infrastructure to support translational cancer research, initially with a focus on lung cancer. Specifically, EnRICH will assemble a prospective cohort of 1000 newly d...

Read more
Epidemiology and health services researchImplementation researchKnowledge translationLung cancer